Unknown Government
Good morning, everybody. Thanks for becoming a member of us right here in New York on the webcast and in individual. At present, Dwight Egan, Chief Government Officer of Co-Diagnostics, will focus on the corporate’s new collaboration with U.Okay.-based ReadyGo Diagnostics, the manufacturing functionality supporting future scale, and the progress underway at CoSara in India.
A number of housekeeping gadgets earlier than we begin. At present’s presentation is being recorded, and a replay might be obtainable within the Investor Relations part of the corporate’s web site. Following the presentation, we’ll take questions.
Please word that sure statements made throughout right now’s presentation that aren’t historic information are forward-looking statements. These embrace statements about product growth, the ReadyGo collaboration, regulatory submissions and timing, manufacturing capability, market alternatives, and commercialization. These statements contain vital dangers and uncertainties.
Precise outcomes might differ materially, and there could be no assurance that anticipated outcomes will happen on a well timed foundation or in any respect. Vital danger elements are described within the firm’s filings with the Securities and Change Fee, together with its annual report on Type 10-Okay filed March 31, 2026. Co-Diagnostics undertakes no obligation to replace or revise these statements.
The Co-Dx PCR platform is topic to FDA assessment and isn’t at the moment on the market. The blood-based purposes mentioned right now stay in growth and require additional validation and relevant regulatory authorization.
This presentation is just not a proposal to promote or a solicitation to purchase securities and shouldn’t type the idea of an funding choice. At present’s presentation additionally contains info relating to different firms, together with public reported market dimension and valuation knowledge. That info is derived from public sources and third-party estimates that we’ve not independently verified. It’s offered as market context solely. It’s